Market-Moving News for October 8th
Market-Moving News for October 8th
BPTH: 74% | Bio-Path Has Initiated A Therapeutic Program To Develop BP1001-A For Obesity And Related Metabolic Diseases, This Program Marks The First Application Of DNAbilize Technology For Development Of A Non-cancer Application
BPTH: 74% | Bio-Path已启动治疗计划，开发BP1001-A用于肥胖和相关代谢性疾病，这个计划标志着DNAbilize 科技首次应用于非癌症应用的开发。
DOCU: 6% | DocuSign shares are trading higher after it was announced the company will join the S&P MidCap 400.
DOCU: 6% | DocuSign股票上涨，因公司宣布将加入S&P MidCap 400指数。
SAGE: -26% | Sage Therapeutics shares are trading lower after the company stops further development of dalzanemdor in Alzheimer's Disease following disappointing results from the Phase 2 LIGHTWAVE Study.
SAGE: -26% | sage therapeutics股票下跌，因公司决定停止在阿尔茨海默症中进一步开发dalzanemdor，此举是基于第2期LIGHTWAVE研究结果令人失望。
